CRISPR/Cas9-Engineered HLA-Deleted Glomerular Endothelial Cells as a Tool to Predict Pathogenic Non-HLA Antibodies in Kidney Transplant Recipients.-论文-万方医学网

作者： Baptiste,Lamarthée ^[1] ; Carole,Burger ^[1] ; Charlotte,Leclaire ^[1] ; Emilie,Lebraud ^[1] ; Aniela,Zablocki ^[1] ; Lise,Morin ^[1] ; Xavier,Lebreton ^[2] ; Béatrice,Charreau ^[3] ; Renaud,Snanoudj ^[4] ; Soëli,Charbonnier ^[5] ; Tifanie,Blein ^[5] ; Mélanie,Hardy ^[6] ; Julien,Zuber ^[2] ; Simon,Satchell ^[5] ; Morgan,Gallazzini ^[7] ; Fabiola,Terzi ^[1] ; Christophe,Legendre ^[1] ; Jean Luc,Taupin ^[2] ; Marion,Rabant ^[6] ; Claire,Tinel ^[1] ; Dany,Anglicheau ^[8]

作者单位： Necker-Enfants Malades Institute, Institut National de la Santé et de la Recherche Médicale (INSERM) U1151, University of Paris, Paris, France. ^[1] Department of Nephrology and Kidney Transplantation, Necker Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. ^[2] Center for Research in Transplantation and Immunology, INSERM UMR1064, IHU CESTI, LabEx IGO and LabEx Transplantex, Nantes University, Nantes, France. ^[3] Immunology and Histocompatibility Laboratory, Saint-Louis Hospital, AP-HP, LabEx Transplantex, INSERM U1160, University Paris Diderot, Paris, France. ^[4] Laboratory of Human Lymphohematopoiesis, Imagine Institute, INSERM U1163, University of Paris, Paris, France. ^[5] Immunology and Histocompatibility Laboratory, Saint-Louis Hospital, AP-HP, INSERM U976, IRSL, University of Paris, Paris, France. ^[6] Bristol Renal, Bristol Heart Institute, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom. ^[7] Department of Pathology, Necker Hospital, AP-HP, Paris, France. ^[8]

主题词成年人(Adult);老年人(Aged);细胞, 培养的(Cells, Cultured);内皮细胞(Endothelial Cells);女(雌)性(Female);基因缺失(Gene Deletion);移植物排斥(Graft Rejection);HLA抗原(HLA Antigens);人类(Humans);同种抗体(Isoantibodies);肾小球(Kidney Glomerulus);肾移植(Kidney Transplantation);男(雄)性(Male);中年人(Middle Aged);核蛋白质类(Nuclear Proteins);再手术(Reoperation);回顾性研究(Retrospective Studies);组织供者(Tissue Donors);反式激活因子类(Trans-Activators);β2微球蛋白(beta 2-Microglobulin)

DOI 10.1681/ASN.2021050689

PMID 35167486

发布时间 2023-02-06

检索历史清除

CRISPR/Cas9-Engineered HLA-Deleted Glomerular Endothelial Cells as a Tool to Predict Pathogenic Non-HLA Antibodies in Kidney Transplant Recipients.

Journal of the American Society of Nephrology

相似文献

Journal of the American Society of Nephrology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

CRISPR/Cas9-Engineered HLA-Deleted Glomerular Endothelial Cells as a Tool to Predict Pathogenic Non-HLA Antibodies in Kidney Transplant Recipients.

Journal of the American Society of Nephrology

相似文献

Journal of the American Society of Nephrology

相关期刊

检索历史清除